PROC Procaps Group Corp: Long-Term Debt to Capital Coefficient

Symbol and logo of brand Procaps Group Corp (PROC)

Procaps Group S.A. (PROC) owns modern facilities in the US and Latin America, ensuring the reliability of pharmaceutical supplies. This price trend chart on GURU.Markets shows the metric at 0.00, while market distrust is driven by management turnover and reporting errors. Procaps Group S.A. (PROC) is mitigating threats by providing contract services to hundreds of clients and developing its own private labels.

PROC - Procaps Group Long-Term Debt to Equity over the range 07/04/2022 - 02/16/2025

Comprehensive metric breakdowns and analytics for Procaps Group S.A. (PROC)

- price and consensus price forecast:
Quote Chart Procaps Group|PROC - Analyst Consensus Forecast
- market capitalization data:
Market Value Procaps Group|PROC - Enterprise Value
- book capitalization data:
Book Value per Share Procaps|PROC - Company Book Value|Market Value to Book Value procapsgroup.com|PROC - Aggregate Company Assets
- debt and liquidity data:
Total Debt to Equity Ratio Procaps Group S.A.|PROC - Long-Term Debt to Capital|Short-Term Debt to Capital procapsgroup.com|PROC - Company Total Debt|Debt to Net Assets Ratio Procaps Group
Initial company analysis:Procaps Group
Core merchandise of Procaps Group S.A.

The stability of Procaps Group S.A. (PROC) relies on the loyalty of its engineering staff in Latin America. An analysis of long-term debt-to-equity allows for an assessment of how effectively the company finances its expansion amid the current rotation of financial management. This metric compares liabilities with maturities exceeding one year against shareholders' equity, revealing the extent of the debt load. A decrease in this ratio confirms financial resilience. A rational balance of this indicator justifies the fair market value of the asset.

Who Procaps Group S.A. competes with

Long-Term Liabilities to Equity Haleon PLC|Kenvue Corp (KVUE) - Long-Term Debt to Capital|Long-Term Debt to Capital Coefficient Verona Pharma Inc. (VRNA)|Long-Term Debt to Capital MENS (Jyong Biotech Ltd)|ligand.com - Long-Term Debt to Capital|Long-Term Debt to Equity Amneal (AMRX)|PRGO: Long-Term Debt to Capital Coefficient|ALVO (Alvotech Corp) - Long-Term Debt to Equity|Liquidia Inc. (LQDA) - Long-Term Debt to Equity Ratio|GLPG (Galapagos NV) - Long-Term Debt to Capital|Long-Term Debt to Capital anipharmaceuticals.com (ANIP)|MannKind (MNKD) - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital Coefficient AMPH (Amphastar Pharmaceuticals Inc)|PCRX: Long-Term Debt to Equity|SPRY - Long-Term Liabilities to Capital|Long-Term Debt to Equity Ratio Theravance Biopharma TBPH|AQST - Long-Term Loans to Capital Ratio|Long-Term Debt to Capital scpharmaceuticals.com SCPH|Tectonic Therapeutic (TECX) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Capital TNXP (Tonix Pharmaceuticals Inc.)|Long-Term Liabilities to Capital SXTC|Eupraxia Pharmaceuticals (EPRX) - Long-Term Debt to Equity|Long-Term Debt to Capital Coefficient BHST (bioharvest.com)|eXoZymes (EXOZ) - Long-Term Debt to Equity|Oramed - Long-Term Liabilities to Equity|Long-Term Debt to Equity Entera Bio Corp (ENTX)|HYFT: Long-Term Debt to Capital Coefficient|Long-Term Debt to Equity ABVC|cumberlandpharma.com (CPIX) - Long-Term Liabilities to Capital|Long-Term Debt to Capital QNTM|Long-Term Debt to Equity Ratio FibroGen Inc|Long-Term Debt to Capital TELO|Long-Term Debt to Capital RANI (ranitherapeutics.com)|Synergy CHC (SNYR) - Long-Term Debt to Equity|Rallybio Corp - Long-Term Liabilities to Equity|Long-Term Debt to Equity LEXX (Lexaria)|Pulmatrix Inc (PULM) - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity Ratio ftzy.com.cn PTHL|Aptorum Group (APM) - Long-Term Debt to Capital Coefficient|Lyra Therapeutics, Inc. - Long-Term Debt to Capital|Long-Term Indebtedness to Equity IBO|TNF Pharmaceuticals (TNFA) - Long-Term Debt to Equity|Long-Term Debt to Capital Coefficient YCBD (cbdmd.com)|PRFX: Long-Term Debt to Equity|CYTO - Long-Term Liabilities to Capital|Lipella Pharmaceuticals - Long-Term Debt to Equity Ratio|OPTN: Long-Term Debt to Capital|Long-Term Debt to Equity Pieris Pharmaceuticals, Inc. (PIRS)|Long-Term Liabilities to Equity Petros Pharmaceuticals Inc|QLI - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital Coefficient SLRN|TFFP (TFF Pharmaceuticals) - Long-Term Debt to Equity